Immune Checkpoint Inhibitor Treatment Toxicity Risk in RA Immune Checkpoint Inhibitor Treatment Toxicity Risk in RA

A new analysis investigates the potential for patients with rheumatoid arthritis to experience adverse events after treatment with immune checkpoint inhibitors.Journal of Clinical Rheumatology
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Rheumatology Journal Article Source Type: news